Wilmington, DE, United States of America

Richard C Ebersole

USPTO Granted Patents = 37 


Average Co-Inventor Count = 2.6

ph-index = 17

Forward Citations = 1,043(Granted Patents)


Location History:

  • Newark, DE (US) (1980 - 2003)
  • Wilmington, DE (US) (1985 - 2014)

Company Filing History:


Years Active: 1980-2014

Loading Chart...
Loading Chart...
37 patents (USPTO):Explore Patents

Title: Richard C. Ebersole: Innovator in DNA and RNA Detection Technologies

Introduction: Richard C. Ebersole, based in Wilmington, Delaware, is a prolific inventor with an impressive record of 37 patents. His work focuses primarily on advancements in the field of molecular biology, specifically concerning DNA and RNA detection methodologies.

Latest Patents: Among his most recent innovations are two key patents. The first patent involves a method, kit, and system for collecting and processing samples for DNA and RNA detection. This invention streamlines the release and treatment of genetic material, enabling rapid and convenient recovery of DNA and RNA from various tissues and cellular materials. The second patent is centered around the development of primers for the detection of the white spot syndrome virus (WSSV). These primers, derived from a novel segment of the WSSV genome, facilitate diagnostic methods, including primer-directed amplification and nucleic acid hybridization assays.

Career Highlights: Ebersole has contributed significantly to the field of biotechnology through his tenure at renowned companies like E.I. DuPont De Nemours and Company. His work at such established institutions underscores his commitment to innovation and the advancement of genetic detection technologies.

Collaborations: Throughout his career, Richard has collaborated with notable professionals in the field, including Jianzhong Zhang and Mario W. Chen. These partnerships have been instrumental in fostering advancements in molecular detection techniques and amplifying the impact of his inventions.

Conclusion: Richard C. Ebersole's extensive portfolio of patents and his dedication to innovation in the biotechnology sector position him as a key player in the realm of DNA and RNA detection. His recent patents not only advance scientific knowledge but also have the potential to revolutionize diagnostic practices in various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…